RICHARD A. GONZALEZ	title	Chairman of the Board	RICHARD A. GONZALEZ,  Chairman of the Board and Chief Executive Officer,  Rick Gonzalez is Chairman of the Board and Chief Executive Officer,  of AbbVie, a global biopharmaceutical company employing approximately 28,000 people and marketing medicines in more than 170 countries. Prior to AbbVie's separation from Abbott, Mr. Gonzalez was a 30-year Abbott veteran. He served as Executive Vice President, Pharmaceutical Products Group, where he led the global pharmaceutical business, including commercial operations, research and development and manufacturing. He also served as President and Chief Operating Officer, prior to a brief retirement.
RICHARD A. GONZALEZ	title	Chief Executive Officer	RICHARD A. GONZALEZ,  Chairman of the Board and Chief Executive Officer,  Rick Gonzalez is Chairman of the Board and Chief Executive Officer,  of AbbVie, a global biopharmaceutical company employing approximately 28,000 people and marketing medicines in more than 170 countries. Prior to AbbVie's separation from Abbott, Mr. Gonzalez was a 30-year Abbott veteran. He served as Executive Vice President, Pharmaceutical Products Group, where he led the global pharmaceutical business, including commercial operations, research and development and manufacturing. He also served as President and Chief Operating Officer, prior to a brief retirement.
LAURA J. SCHUMACHER	title	Executive Vice President	LAURA J. SCHUMACHER,  Executive Vice President, External Affairs, General Counsel and Corporate Secretary,  Laura Schumacher is Executive Vice President, External Affairs, General Counsel and Corporate Secretary, , responsible for AbbVie’s externally-facing functions of Health Economics Outcomes Research, Government Affairs, Corporate Responsibility, Brand and Communications. She also leads all Legal functions and Biotherapeutics Strategy. Prior to AbbVie’s separation from Abbott, Ms. Schumacher served as Executive Vice President, General Counsel and Secretary, where she also had responsibility for the Office of Ethics and Compliance. Both at Abbott and AbbVie, Ms. Schumacher has led Licensing & Acquisitions and Ventures and Early Stage Collaborations. She serves on the board of General Dynamics.
LAURA J. SCHUMACHER	title	External Affairs	LAURA J. SCHUMACHER,  Executive Vice President, External Affairs, General Counsel and Corporate Secretary,  Laura Schumacher is Executive Vice President, External Affairs, General Counsel and Corporate Secretary, , responsible for AbbVie’s externally-facing functions of Health Economics Outcomes Research, Government Affairs, Corporate Responsibility, Brand and Communications. She also leads all Legal functions and Biotherapeutics Strategy. Prior to AbbVie’s separation from Abbott, Ms. Schumacher served as Executive Vice President, General Counsel and Secretary, where she also had responsibility for the Office of Ethics and Compliance. Both at Abbott and AbbVie, Ms. Schumacher has led Licensing & Acquisitions and Ventures and Early Stage Collaborations. She serves on the board of General Dynamics.
LAURA J. SCHUMACHER	title	General Counsel	LAURA J. SCHUMACHER,  Executive Vice President, External Affairs, General Counsel and Corporate Secretary,  Laura Schumacher is Executive Vice President, External Affairs, General Counsel and Corporate Secretary, , responsible for AbbVie’s externally-facing functions of Health Economics Outcomes Research, Government Affairs, Corporate Responsibility, Brand and Communications. She also leads all Legal functions and Biotherapeutics Strategy. Prior to AbbVie’s separation from Abbott, Ms. Schumacher served as Executive Vice President, General Counsel and Secretary, where she also had responsibility for the Office of Ethics and Compliance. Both at Abbott and AbbVie, Ms. Schumacher has led Licensing & Acquisitions and Ventures and Early Stage Collaborations. She serves on the board of General Dynamics.
LAURA J. SCHUMACHER	title	Corporate Secretary	LAURA J. SCHUMACHER,  Executive Vice President, External Affairs, General Counsel and Corporate Secretary,  Laura Schumacher is Executive Vice President, External Affairs, General Counsel and Corporate Secretary, , responsible for AbbVie’s externally-facing functions of Health Economics Outcomes Research, Government Affairs, Corporate Responsibility, Brand and Communications. She also leads all Legal functions and Biotherapeutics Strategy. Prior to AbbVie’s separation from Abbott, Ms. Schumacher served as Executive Vice President, General Counsel and Secretary, where she also had responsibility for the Office of Ethics and Compliance. Both at Abbott and AbbVie, Ms. Schumacher has led Licensing & Acquisitions and Ventures and Early Stage Collaborations. She serves on the board of General Dynamics.
WILLIAM J. CHASE	title	Executive Vice President	WILLIAM J. CHASE,  Executive Vice President, Chief Financial Officer,  Bill Chase is Executive Vice President, Chief Financial Officer, . Prior to AbbVie's separation from Abbott, Mr. Chase served as Vice President, Licensing and Acquisitions. He has also served as Vice President and Treasurer, Divisional Vice President and Controller for the global pharmaceutical business.
WILLIAM J. CHASE	title	Chief Financial Officer	WILLIAM J. CHASE,  Executive Vice President, Chief Financial Officer,  Bill Chase is Executive Vice President, Chief Financial Officer, . Prior to AbbVie's separation from Abbott, Mr. Chase served as Vice President, Licensing and Acquisitions. He has also served as Vice President and Treasurer, Divisional Vice President and Controller for the global pharmaceutical business.
CARLOS ALBAN	title	Executive Vice President	CARLOS ALBAN,  Executive Vice President, Commercial Operations,  Carlos Alban is Executive Vice President, Commercial Operations, . Prior to AbbVie's separation from Abbott, Mr. Alban served as Senior Vice President, Proprietary Pharmaceutical Products, Global Commercial Operations. He held a number of management positions in the international pharmaceutical business.
CARLOS ALBAN	employee_of	Commercial Operations	CARLOS ALBAN,  Executive Vice President, Commercial Operations,  Carlos Alban is Executive Vice President, Commercial Operations, . Prior to AbbVie's separation from Abbott, Mr. Alban served as Senior Vice President, Proprietary Pharmaceutical Products, Global Commercial Operations. He held a number of management positions in the international pharmaceutical business.
MICHAEL E. SEVERINO	title	Executive Vice President	MICHAEL E. SEVERINO, M.D. ,  Executive Vice President, Research & Development and Chief Scientific Officer ,  Dr. Severino is the Executive Vice President, Research & Development and Chief Scientific Officer of AbbVie. He previously served as Senior Vice President, Global Development and Corporate Chief Medical Officer at Amgen Inc. Dr. Severino held other management roles at Amgen, Inc., including Vice President, Global Development and Vice President, Therapeutic Area Head, General Medicine and Inflammation Global Clinical Development. He joined AbbVie in 2014.
MICHAEL E. SEVERINO	title	Chief Scientific Officer	MICHAEL E. SEVERINO, M.D. ,  Executive Vice President, Research & Development and Chief Scientific Officer ,  Dr. Severino is the Executive Vice President, Research & Development and Chief Scientific Officer of AbbVie. He previously served as Senior Vice President, Global Development and Corporate Chief Medical Officer at Amgen Inc. Dr. Severino held other management roles at Amgen, Inc., including Vice President, Global Development and Vice President, Therapeutic Area Head, General Medicine and Inflammation Global Clinical Development. He joined AbbVie in 2014.
MICHAEL E. SEVERINO	employee_of	Research & Development	MICHAEL E. SEVERINO, M.D. ,  Executive Vice President, Research & Development and Chief Scientific Officer ,  Dr. Severino is the Executive Vice President, Research & Development and Chief Scientific Officer of AbbVie. He previously served as Senior Vice President, Global Development and Corporate Chief Medical Officer at Amgen Inc. Dr. Severino held other management roles at Amgen, Inc., including Vice President, Global Development and Vice President, Therapeutic Area Head, General Medicine and Inflammation Global Clinical Development. He joined AbbVie in 2014.
HENRY O. GOSEBRUCH	title	Executive Vice President	HENRY O. GOSEBRUCH,  Executive Vice President and Chief Strategy Officer,  Mr. Gosebruch is Executive Vice President and Chief Strategy Officer, . Prior to joining AbbVie in 2015, Mr. Gosebruch worked for more than 20 years in the Mergers & Acquisitions Group at J.P. Morgan Securities LLC, most recently as Co-Head of M&A North America.
HENRY O. GOSEBRUCH	title	Chief Strategy Officer	HENRY O. GOSEBRUCH,  Executive Vice President and Chief Strategy Officer,  Mr. Gosebruch is Executive Vice President and Chief Strategy Officer, . Prior to joining AbbVie in 2015, Mr. Gosebruch worked for more than 20 years in the Mergers & Acquisitions Group at J.P. Morgan Securities LLC, most recently as Co-Head of M&A North America.
TIMOTHY J. RICHMOND	title	Senior Vice President	TIMOTHY J. RICHMOND,  Senior Vice President, Human Resources,  Tim Richmond is Senior Vice President, Human Resources, . Prior to AbbVie's separation from Abbott, Mr. Richmond served as Divisional Vice President, Compensation and Benefits. He also served as Divisional Vice President, Talent Acquisition.
TIMOTHY J. RICHMOND	employee_of	Human Resources	TIMOTHY J. RICHMOND,  Senior Vice President, Human Resources,  Tim Richmond is Senior Vice President, Human Resources, . Prior to AbbVie's separation from Abbott, Mr. Richmond served as Divisional Vice President, Compensation and Benefits. He also served as Divisional Vice President, Talent Acquisition.
AZITA SALEKI-GERHARDT	title	Senior Vice President	AZITA SALEKI-GERHARDT, Ph.D.,  Senior Vice President, Operations,  Azita Saleki-Gerhardt is Senior Vice President, Operations, . Prior to AbbVie's separation from Abbott, Dr. Saleki-Gerhardt was Vice President, Pharmaceuticals, Manufacturing and Supply.
AZITA SALEKI-GERHARDT	employee_of	Operations	AZITA SALEKI-GERHARDT, Ph.D.,  Senior Vice President, Operations,  Azita Saleki-Gerhardt is Senior Vice President, Operations, . Prior to AbbVie's separation from Abbott, Dr. Saleki-Gerhardt was Vice President, Pharmaceuticals, Manufacturing and Supply.
KAREN HALE	title	Vice President	KAREN HALE,  Vice President, Chief Ethics and Compliance Officer,  Karen Hale is Vice President, Chief Ethics and Compliance Officer, . Prior to her current role, Ms. Hale was Vice President and Associate General Counsel, Litigation & Legal Specialty Operations.
KAREN HALE	title	Chief Ethics and Compliance Officer	KAREN HALE,  Vice President, Chief Ethics and Compliance Officer,  Karen Hale is Vice President, Chief Ethics and Compliance Officer, . Prior to her current role, Ms. Hale was Vice President and Associate General Counsel, Litigation & Legal Specialty Operations.
WULFF‐ERIK VON BORCKE	title	President	WULFF‐ERIK VON BORCKE,  President, Pharmacyclics,  Erik von Borcke is President of Pharmacyclics, a wholly-owned subsidiary of AbbVie that operates from its Sunnyvale, California headquarters. Erik held a number of leadership positions within Abbott and AbbVie’s global pharmaceutical business, including his most recent role as Vice President, Global Marketing, where he led the global marketing of AbbVie products across all therapeutic areas.
WULFF‐ERIK VON BORCKE	employee_of	Pharmacyclics	WULFF‐ERIK VON BORCKE,  President, Pharmacyclics,  Erik von Borcke is President of Pharmacyclics, a wholly-owned subsidiary of AbbVie that operates from its Sunnyvale, California headquarters. Erik held a number of leadership positions within Abbott and AbbVie’s global pharmaceutical business, including his most recent role as Vice President, Global Marketing, where he led the global marketing of AbbVie products across all therapeutic areas.
